Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katsuto Takenaka

Showing results (1-10 of 204) with videos related to

Pageof 21
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 20, 2015
[Xenotransplantation assay for cancer stem cells]Katsuto Takenaka
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 9, 2019
[Clinical application of gene mutation information in myeloproliferative neoplasms]Katsuto Takenaka
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 26, 2013
[Virus infection after allogeneic hematopoietic stem cell transplantation]Katsuto Takenaka
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2016
Myeloproliferative neoplasms: updates on molecular pathophysiology, diagnosis and treatment strategiesKatsuto Takenaka
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 6, 2012
[Progress in xenotransplantation model for human hematopoietic stem cell assay]Katsuto Takenaka
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 8, 2015
[Cytomegalovirus reactivation after allogeneic stem cell transplantation reduces the risk of relapse in patients with acute myeloid leukemia]Katsuto Takenaka
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 1, 2023
[Allogeneic hematopoietic cell transplantation for myeloproliferative neoplasms]Katsuto Takenaka
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2020
[Recent advances in the treatment of myelofibrosis]Katsuto Takenaka
International Journal of Hematology|January 8, 2020
Progress in elucidation of molecular pathophysiology and its application in therapeutic decision-making for myeloproliferative neoplasmsKatsuto Takenaka
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 11, 2019
[Allogeneic hematopoietic stem cell transplantation for myeloproliferative neoplasms]Katsuto Takenaka
Pageof 21

Showing results (1-10 of 204) with videos related to

Sort By:
Pageof 21
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 20, 2015
[Xenotransplantation assay for cancer stem cells]Katsuto Takenaka
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 9, 2019
[Clinical application of gene mutation information in myeloproliferative neoplasms]Katsuto Takenaka
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 26, 2013
[Virus infection after allogeneic hematopoietic stem cell transplantation]Katsuto Takenaka
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2016
Myeloproliferative neoplasms: updates on molecular pathophysiology, diagnosis and treatment strategiesKatsuto Takenaka
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 6, 2012
[Progress in xenotransplantation model for human hematopoietic stem cell assay]Katsuto Takenaka
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 8, 2015
[Cytomegalovirus reactivation after allogeneic stem cell transplantation reduces the risk of relapse in patients with acute myeloid leukemia]Katsuto Takenaka
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 1, 2023
[Allogeneic hematopoietic cell transplantation for myeloproliferative neoplasms]Katsuto Takenaka
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2020
[Recent advances in the treatment of myelofibrosis]Katsuto Takenaka
International Journal of Hematology|January 8, 2020
Progress in elucidation of molecular pathophysiology and its application in therapeutic decision-making for myeloproliferative neoplasmsKatsuto Takenaka
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 11, 2019
[Allogeneic hematopoietic stem cell transplantation for myeloproliferative neoplasms]Katsuto Takenaka
Pageof 21